Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies
DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures ...
Colossal, the company known for its mission to resurrect a woolly mammoth (or at least, an elephant with some very mammoth-like traits), is back with $60 million in Series A funding. But despite the ...
Funding allows for expansion of labs, teams, and additional species candidates for de-extinction DALLAS–(BUSINESS WIRE)–January 15, 2025– Colossal Biosciences, the world’s first de-extinction company, ...
Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies
Funding will accelerate the development of breakthrough genetic tools and technologies including software, wetware, and artificial wombs to advance species preservation and restoration as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback